Krilogy Financial LLC Zynerba Pharmaceuticals, Inc. Transaction History

Krilogy Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.89 - $7.91 $289 - $791	-100 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.59 - $10.45 $559 - $1,045	100 New	100 $1,000
Q2 2018 Aug 15, 2018	SELL	$7.98 - $12.39 $798 - $1,239	-100 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$8.49 - $13.46 $1,120 - $1,776	-132 Reduced 56.9%	100 $1,000
Q2 2017 Aug 15, 2017	BUY	N/A	232	232 $4,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.